Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.90 Analyst target: $3.17 Upside: 9.02%
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the regions from Asia Pacific. The company is headquartered in Billerica, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.